Maine Biotechnology Services is a premier provider of antibody services, from design and development to production and characterization. MBS extends the creativity and experience necessary for more complex hybridoma development projects, including small molecules and anti-idiotypic. MBS’s development tools and expertise benefit not only service customers but also product customers as these tools are applied in the internal development of new antibody products. MBS was founded in 1990 by Dr. Joseph Chandler and continues to be wholly owned and operated in Maine.
Browse our site to learn more about our antibody experience and capabilities.